Requirements for Proper Immunosuppressive Regimens to Limit Translational Failure of Cardiac Cell Therapy in Preclinical Large Animal Models

Overview

Journal J Cardiovasc Transl Res

Publisher Springer

Specialty Cardiology & Vascular Diseases

Date 2020 Jun 2

PMID 32476086

Citations 4

Authors

Evelyne J Demkes

Simone Rijken

Mariusz K Szymanski

Imo E Hoefer

Joost P G Sluijter

Saskia C A de Jager

Affiliations

Soon will be listed here.

Abstract

Various cell-based therapies are currently investigated in an attempt to tackle the high morbidity and mortality associated with heart failure. The need for these therapies to move towards the clinic is pressing. Therefore, preclinical large animal studies that use non-autologous cells are needed to evaluate their potential. However, non-autologous cells are highly immunogenic and trigger immune rejection responses resulting in potential loss of efficacy. To overcome this issue, adequate immunosuppressive regimens are of imminent importance but clear guidelines are currently lacking. In this review, we assess the immunological barriers regarding non-autologous cell transplantation and immune modulation with immunosuppressive drugs. In addition, we provide recommendations with respect to immunosuppressive regimens in preclinical cardiac cell-replacement studies.

Citing Articles

Human Cardiac Microtissues Display Improved Engraftment and Survival in a Porcine Model of Myocardial Infarction.

Demkes E, Cervera-Barea A, Ebner-Peking P, Wolf M, Hochmann S, Scheren A J Cardiovasc Transl Res. 2025; .

PMID: 40082315 DOI: 10.1007/s12265-025-10596-0.

Non-human primate studies for cardiomyocyte transplantation-ready for translation?.

von Bibra C, Hinkel R Front Pharmacol. 2024; 15:1408679.

PMID: 38962314 PMC: 11221829. DOI: 10.3389/fphar.2024.1408679.

Unlocking the Mysteries, Bridging the Gap, and Unveiling the Multifaceted Potential of Stem Cell Therapy for Cardiac Tissue Regeneration: A Narrative Review of Current Literature, Ethical Challenges, and Future Perspectives.

Abubakar M, Masood M, Javed I, Adil H, Faraz M, Bhat R Cureus. 2023; 15(7):e41533.

PMID: 37551212 PMC: 10404462. DOI: 10.7759/cureus.41533.

Large animal models for cardiac remuscularization studies: A methodological review.

Yu Y, Tham S, Roslan F, Shaharuddin B, Yong Y, Guo Z Front Cardiovasc Med. 2023; 10:1011880.

PMID: 37008331 PMC: 10050756. DOI: 10.3389/fcvm.2023.1011880.

Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.

Wang X, Brown N, Wang B, Shariati K, Wang K, Fuchs S Adv Sci (Weinh). 2021; 8(17):e2003708.

PMID: 34258870 PMC: 8425879. DOI: 10.1002/advs.202003708.

References

Liu Z, Sun Y, Xi Y, Maffei A, Reed E, Harris P . Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med. 1993; 177(6):1643-50. PMC: 2191044. DOI: 10.1084/jem.177.6.1643. View

Stehlik J, Edwards L, Kucheryavaya A, Benden C, Christie J, Dobbels F . The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011. J Heart Lung Transplant. 2011; 30(10):1078-94. DOI: 10.1016/j.healun.2011.08.003. View

Dandel M, Jasaityte R, Lehmkuhl H, Knosalla C, Hetzer R . Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation. Transplant Proc. 2009; 41(6):2585-8. DOI: 10.1016/j.transproceed.2009.06.031. View

Ponikowski P, Voors A, Anker S, Bueno H, Cleland J, Coats A . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special.... Eur Heart J. 2016; 37(27):2129-2200. DOI: 10.1093/eurheartj/ehw128. View

Zhao S, Xu Z, Wang H, Reese B, Gushchina L, Jiang M . Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction. Nat Commun. 2016; 7:13306. PMC: 5095349. DOI: 10.1038/ncomms13306. View

Ye L, Chang Y, Xiong Q, Zhang P, Zhang L, Somasundaram P . Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell. 2014; 15(6):750-61. PMC: 4275050. DOI: 10.1016/j.stem.2014.11.009. View

Shiba Y, Gomibuchi T, Seto T, Wada Y, Ichimura H, Tanaka Y . Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature. 2016; 538(7625):388-391. DOI: 10.1038/nature19815. View

Barbarino J, Staatz C, Venkataramanan R, Klein T, Altman R . PharmGKB summary: cyclosporine and tacrolimus pathways. Pharmacogenet Genomics. 2013; 23(10):563-85. PMC: 4119065. DOI: 10.1097/FPC.0b013e328364db84. View

Webster A, Woodroffe R, Taylor R, Chapman J, Craig J . Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data. BMJ. 2005; 331(7520):810. PMC: 1246079. DOI: 10.1136/bmj.38569.471007.AE. View

10.

Kempf H, Kropp C, Olmer R, Martin U, Zweigerdt R . Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nat Protoc. 2015; 10(9):1345-61. DOI: 10.1038/nprot.2015.089. View

11.

Curtis J, Westfall A, Allison J, Bijlsma J, Freeman A, George V . Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 2006; 55(3):420-6. DOI: 10.1002/art.21984. View

12.

Zhu K, Wu Q, Ni C, Zhang P, Zhong Z, Wu Y . Lack of Remuscularization Following Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitor Cells in Infarcted Nonhuman Primates. Circ Res. 2018; 122(7):958-969. DOI: 10.1161/CIRCRESAHA.117.311578. View

13.

Madonna R, van Laake L, Botker H, Davidson S, De Caterina R, Engel F . ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure. Cardiovasc Res. 2019; 115(3):488-500. PMC: 6383054. DOI: 10.1093/cvr/cvz010. View

14.

Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A . Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Stem Cell Reports. 2016; 6(3):312-20. PMC: 4788782. DOI: 10.1016/j.stemcr.2016.01.012. View

15.

Ziaeian B, Fonarow G . Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016; 13(6):368-78. PMC: 4868779. DOI: 10.1038/nrcardio.2016.25. View

16.

Kino T, Hatanaka H, Miyata S, Inamura N, Nishiyama M, Yajima T . FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo). 1987; 40(9):1256-65. DOI: 10.7164/antibiotics.40.1256. View

17.

Meier R, Muller Y, Balaphas A, Morel P, Pascual M, Seebach J . Xenotransplantation: back to the future?. Transpl Int. 2017; 31(5):465-477. DOI: 10.1111/tri.13104. View

18.

Brown K, Sacks S, Wong W . Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J. 2008; 22(11):3776-84. DOI: 10.1096/fj.08-107441. View

19.

Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster C . Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016; 15(4):457-65. DOI: 10.1517/14740338.2016.1140743. View

20.

Zimmermann W, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U . Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006; 12(4):452-8. DOI: 10.1038/nm1394. View